Schedule a Meeting

2020 ADA Standards of Care just arrived and now includes AI to prevent blindness

The American Diabetes Association’s 2020 Standards of Medical Care in Diabetes now include FDA-authorized artificial intelligence systems that detect diabetic retinopathy and macular edema.

(CORALVILLE, Iowa) December 23, 2019 – The nation’s leading association that fights against diabetes released a new set of clinical standards that for the first time include the use of autonomous artificial intelligence (AI).

The American Diabetes Association (ADA)’s 2020 Standards of Medical Care in Diabetes states that “AI systems that detect more than mild diabetic retinopathy and diabetic macular edema authorized for use by the FDA represent an alternative to traditional screening approaches.”

To date, LumineticsCore™ (formerly known as IDx-DR) is the first and only FDA-authorized autonomous AI diagnostic system for the detection of diabetic retinopathy and macular edema. It is currently in use at a number of large health systems that each serve tens of thousands of people with diabetes and have struggled to implement diabetic retinopathy eye exams at scale for their large diabetes population.

“The ADA’s inclusion of our technology in its Standards of Care marks a significant move toward mainstream adoption of autonomous AI in clinical care,” said Michael Abramoff, MD, PhD, Founder and Executive Chairman at IDx. “Our early customers are visionary leaders who foresaw that autonomous AI would one day become a standard of care for diabetic retinopathy screening, and taking that leap is paying off for them. Already, health systems that are using LumineticsCore (formerly known as IDx-DR) have experienced significant improvements in accessibility, efficiency and compliance rates, unleashing massive potential for cost savings and improved patient outcomes.”

The Standards of Care were published last week in Diabetes Care, the highest-ranked, peer-reviewed journal in the field of diabetes treatment and prevention. Physicians, healthcare systems, health insurers and quality of care organizations look to the ADA’s Standards of Care for consensus and evidence-based best practices to improve health outcomes for people with diabetes.